Jeri Sumitani
Impact in
- Virology top 10%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 15
- HIV/AIDS drug development and treatment 4
-
- HIV, Drug Use, Sexual Risk 4
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- A. Rana Bayakly (1 shared paper)Nancy L. Fleischer (1 shared paper)Jonathan Colasanti (6 shared papers)Wendy S. Armstrong (6 shared papers)Hope M. Tiesman (1 shared paper)Matthew Murphy (1 shared paper)C. Christina Mehta (1 shared paper)Minh Ly Nguyen (1 shared paper)
- Journals
- Open Forum Infectious Diseases (4 papers)AIDS Care (2 papers)Clinical Infectious Diseases (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)AIDS (1 paper)
- Partner nations
- United StatesSouth AfricaRepublic of the Congo
In The Last Decade
Jeri Sumitani
15 papers receiving 338 citations
Peers
Comparison fields: 5 of 54
- Virology 66
- Infectious Diseases 205
- Health, Toxicology and Mutagenesis 91
- General Health Professions 102
- Epidemiology 98
Countries citing papers authored by Jeri Sumitani
This map shows the geographic impact of Jeri Sumitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeri Sumitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeri Sumitani more than expected).
Fields of papers citing papers by Jeri Sumitani
This network shows the impact of papers produced by Jeri Sumitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeri Sumitani. The network helps show where Jeri Sumitani may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeri Sumitani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 106 | |
| 2 | 2018 | 73 | |
| 3 | 2022 | 44 | |
| 4 | 2017 | 36 | |
| 5 | 2016 | 21 | |
| 6 | 2021 | 18 | |
| 7 | 2015 | 13 | |
| 8 | 2024 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2015 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2016 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2024 | 0 |
About Jeri Sumitani
Jeri Sumitani is a scholar working on Infectious Diseases, Epidemiology, General Health Professions, Information Systems and Virology, having authored 17 papers that have together received 342 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (4 papers), HIV/AIDS drug development and treatment (4 papers), Mobile Health and mHealth Applications (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), ICT in Developing Communities (3 papers), HIV Research and Treatment (2 papers) and Sex work and related issues (2 papers). The work is most often cited by research in Virology (66 citations), Infectious Diseases (205 citations), Health, Toxicology and Mutagenesis (91 citations), General Health Professions (102 citations) and Epidemiology (98 citations). Jeri Sumitani has collaborated with scholars based in United States, South Africa and Republic of the Congo. Frequent co-authors include A. Rana Bayakly, Nancy L. Fleischer, Jonathan Colasanti, Wendy S. Armstrong, Hope M. Tiesman, Matthew Murphy, C. Christina Mehta, Minh Ly Nguyen, Carlos del Rı́o and Yiran Zhang. Their work appears in journals such as Open Forum Infectious Diseases, AIDS Care, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.